Alzheimer’s disease therapy navigating barriers using a nanochip

The blood–brain barrier (BBB) has posed a challenge to drug delivery in the medical field, especially in treatment of neurological disorders such as Alzheimer’s disease, for many years now. Nanomedicine has been at the heart of research into how to overcome the hurdles presented by the BBB and researchers from Technion-Israel Institute of Technology (Haifa, Israel) and Bar-Ilan University (Tel Aviv, Israel) have found a promising strategy.   The researchers have inserted a nanochip inside the skull, just outside of the brain (on the dura mater). The chip can then deliver the therapeutic that is needed. For the purpose of their...